Merlin Cyber, a leader in bringing innovative technology solutions to the U.S. Government, and Rimini Street, a global provider of end-to-end enterprise software support, products and services and the leading third-party support provider for Oracle, SAP and VMware products, today announced a strategic partnership to help the U.S. Government cut operating costs through DOGE and other initiatives and modernize existing enterprise software and systems. This press release features multimedia. View ...

Wolters Kluwer, a global leader in professional information, software solutions, and services, has announced the expansion of its cloud infrastructure with the launch of a new TeamCloud Hosting Data Center in Johannesburg, South Africa. This strategic move underscores the commitment to meeting the growing demand from clients across Africa through enabling superior data sovereignty, compliance, and performance. The TeamCloud service offers African organizations enhanced security, reliability, a...

Egle Therapeutics, a clinical-stage biotechnology company developing therapies targeting regulatory T cells (Tregs) for immuno-oncology and autoimmune diseases, will present two posters at the American Association for Cancer Research Annual Meeting (AACR) 2025 being held in Chicago April 25-30, 2025. In the poster, entitled “Preferential tumor uptake and retention of EGL-001, an anti-CTLA4-IL2 mutein fusion antibody achieving selective tumor Treg depletion”. Egle Therapeutics unveils preclini...

Innorna, a clinical-stage biotechnology company revolutionizing mRNA therapeutics with its innovative lipid nanoparticle (LNP) delivery technology, today announced the U.S. Food and Drug Administration (FDA) has granted both Rare Pediatric Disease Designation (RPDD) and Orphan Drug Designation (ODD) to its investigational mRNA therapy, IN013, for treating Wilson Disease (WD). This dual achievement accelerates the clinical development of IN013, advancing Innorna’s mission to deliver transformati...